New FDA approval language for COVID-19 vaccines is sowing confusion about which conditions put people at greater risk for severe disease and who can avoid the inconvenience and cost of off-label ...
Officials at the US Department of Health and Human Services, which awarded funding for the controversial study, say it will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results